Cambridge Cognition Holdings plc (COG) Ordinary 1p
- Add to watchlist
- Create an alert
- This stock can be held in a
Business summary
Cambridge Cognition Holdings plc is a neuroscience technology company. The Company develops and markets digital solutions to assess brain health, principally in the United Kingdom, the United States and Europe. Its products include CANTAB Recruit, CANTAB Connect, Cognition Kit, Cognition eCOA, CANTAB Connect Research, CANTAB Mobile, CANTAB BrainHealth, CANTAB Insight, and NeuroVocalix. CANTAB Recruit is an online trial recruitment platform helping pharmaceutical and biotechnology companies identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease. CANTAB Connect offers digital cognitive assessment solutions for pharmaceutical clinical trials in therapeutic areas from phases I - IV. Cognition Kit is a custom-designed digital health platform delivering wearable and smartphone apps for high frequency data collection. It serves specialist contract research organizations, academic research institutions, and international healthcare providers.
Contact details
Important dates
General stock information
- EPIC:
- COG
- ISIN:
- GB00B8DV9647
- Market cap:
- £18.28 million
- Shares in issue:
- 35.15 million
- Sector:
- Health Care Equipment & Services
- Exchange:
- London Stock Exchange
- Currency:
- Sterling pence
- Indices:
- n/a
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.